Last updated: 23 August 2024 at 5:12pm EST

Simon Nicolas Reade Harford Net Worth




The estimated Net Worth of Simon N.R. Harford is at least $2.27 Million dollars as of 23 January 2023. Mr Harford owns over 102 units of Albireo Pharma Inc stock worth over $1,443,219 and over the last 16 years he sold ALBO stock worth over $134,618. In addition, he makes $687,784 as CFO & Treasurer at Albireo Pharma Inc.

Mr Harford ALBO stock SEC Form 4 insiders trading

Mr has made over 18 trades of the Albireo Pharma Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 102 units of ALBO stock worth $4,468 on 23 January 2023.

The largest trade he's ever made was selling 1,776 units of Albireo Pharma Inc stock on 19 January 2023 worth over $77,789. On average, Mr trades about 111 units every 33 days since 2008. As of 23 January 2023 he still owns at least 32,689 units of Albireo Pharma Inc stock.

You can see the complete history of Mr Harford stock trades at the bottom of the page.





Mr. Simon Nicolas Reade Harford biography

Simon Nicolas Reade Harford is the CFO & Treasurer at Albireo Pharma Inc.

What is the salary of Mr Harford?

As the CFO & Treasurer of Albireo Pharma Inc, the total compensation of Mr Harford at Albireo Pharma Inc is $687,784. There are 7 executives at Albireo Pharma Inc getting paid more, with Ronald Cooper having the highest compensation of $2,995,410.



How old is Mr Harford?

Mr Harford is 60, he's been the CFO & Treasurer of Albireo Pharma Inc since . There are 6 older and 12 younger executives at Albireo Pharma Inc. The oldest executive at Albireo Pharma Inc is Davey Scoon, 73, who is the Independent Director.

What's Mr Harford's mailing address?

Simon's mailing address filed with the SEC is 47 HULFISH STREET, , PRINCETON, NJ, 08542.

Insiders trading at Albireo Pharma Inc

Over the last 8 years, insiders at Albireo Pharma Inc have traded over $26,339,822 worth of Albireo Pharma Inc stock and bought 932,623 units worth $30,497,757 . The most active insiders traders include Advisors Llcperceptive Life..., Roger Jeffs, and Plcastrazeneca Ab Astrazeneca. On average, Albireo Pharma Inc executives and independent directors trade stock every 19 days with the average trade being worth of $957,260. The most recent stock trade was executed by Pamela Stephenson on 23 January 2023, trading 102 units of ALBO stock currently worth $4,468.



What does Albireo Pharma Inc do?

Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.



What does Albireo Pharma Inc's logo look like?

Albireo Pharma Inc logo

Complete history of Mr Harford stock trades at Albireo Pharma Inc and Amicus Therapeutics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
23 Jan 2023 Simon N.R. Harford
CFO and Treasurer
Sale 102 $43.80 $4,468
23 Jan 2023
32,689
19 Jan 2023 Simon N.R. Harford
CFO and Treasurer
Sale 1,776 $43.80 $77,789
19 Jan 2023
32,791
24 Oct 2022 Simon N.R. Harford
CFO and Treasurer
Sale 104 $19.58 $2,036
24 Oct 2022
33,295
11 Oct 2022 Simon N.R. Harford
CFO and Treasurer
Sale 80 $23.79 $1,903
11 Oct 2022
33,399
22 Jul 2022 Simon N.R. Harford
CFO and Treasurer
Sale 106 $24.67 $2,615
22 Jul 2022
33,479
12 Jul 2022 Simon N.R. Harford
CFO and Treasurer
Sale 95 $24.03 $2,283
12 Jul 2022
33,585
22 Apr 2022 Simon N.R. Harford
CFO and Treasurer
Sale 103 $32.92 $3,391
22 Apr 2022
33,680
11 Apr 2022 Simon N.R. Harford
CFO and Treasurer
Sale 96 $35.74 $3,431
11 Apr 2022
33,783
24 Jan 2022 Simon N.R. Harford
CFO and Treasurer
Sale 416 $24.88 $10,350
24 Jan 2022
33,879
11 Jan 2022 Simon N.R. Harford
CFO and Treasurer
Sale 111 $25.95 $2,880
11 Jan 2022
12,695
11 Oct 2021 Simon N.R. Harford
CFO and Treasurer
Sale 93 $30.23 $2,811
11 Oct 2021
12,614
13 Jul 2021 Simon N.R. Harford
CFO and Treasurer
Sale 98 $35.02 $3,432
13 Jul 2021
12,707
12 Apr 2021 Simon N.R. Harford
CFO and Treasurer
Sale 92 $32.12 $2,955
12 Apr 2021
12,196
11 Jan 2021 Simon N.R. Harford
CFO and Treasurer
Sale 110 $37.33 $4,106
11 Jan 2021
4,614
12 Oct 2020 Simon N.R. Harford
CFO and Treasurer
Sale 90 $37.30 $3,357
12 Oct 2020
4,616
10 Jul 2020 Simon N.R. Harford
CFO and Treasurer
Sale 92 $25.56 $2,352
10 Jul 2020
4,706
13 Apr 2020 Simon N.R. Harford
CFO and Treasurer
Sale 97 $16.52 $1,602
13 Apr 2020
4,798
10 Jan 2020 Simon N.R. Harford
CFO and Treasurer
Sale 105 $27.20 $2,856
10 Jan 2020
4,895


Albireo Pharma Inc executives and stock owners

Albireo Pharma Inc executives and other stock owners filed with the SEC include: